Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!

Cancer. 2023 Jul 15;129(14):2266-2267. doi: 10.1002/cncr.34833. Epub 2023 May 3.

Author

Ahmet Emre Eşkazan¹

Affiliation

¹ Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.

PMID: 37138373
DOI: 10.1002/cncr.34833

No abstract available

Publication types

Letter

MeSH terms

Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
Leukemia, Myeloid*
Obesity / complications
Obesity / surgery
Protein Kinase Inhibitors / pharmacology
Protein Kinase Inhibitors / therapeutic use
Tyrosine Kinase Inhibitors

Substances

Tyrosine Kinase Inhibitors
Protein Kinase Inhibitors